猪链球菌血清型2荚膜多糖结合疫苗的研制与免疫学评价
本研究从40株临床分离株中筛选出一株快速生长的猪链球菌血清型2(SS2)菌株,建立了一种无需柱层析、每升培养物可回收克级CPS2的纯化新方法;在小鼠中比较天然与去唾液酸化CPS2结合物的抗体应答未见显著差异;天然CPS2结合疫苗在猪中诱导了强IgG应答并对强毒SS2攻击提供显著保护。
要点
- 建立了一种结合聚乙烯亚胺核酸沉淀与苯酚蛋白变性的CPS2纯化方法,无需柱层析且保持结构完整。
- 小鼠中天然与去唾液酸化CPS2结合物诱导的抗体应答无显著差异。
- 天然CPS2结合疫苗在猪中诱导强IgG应答并对强毒SS2攻击提供显著保护。
核心结论
- 研究建立了高效的CPS2生产平台,明确唾液酸对结合物诱导抗体应答影响有限,并提示CPS2结合物是抗SS2感染的有前景疫苗候选。
研究设计与样本
- 从40株临床分离株中筛选出一株快速生长的SS2菌株,建立CPS2纯化方法。
- 在小鼠中比较天然与去唾液酸化CPS2结合物诱导的抗体应答。
- 在猪中评价天然CPS2结合疫苗的免疫原性与攻毒保护效果,并考察不同佐剂和剂量的影响。
主要发现
- 纯化方法每升培养物可回收克级CPS2,且保持结构完整。
- 小鼠中天然与去唾液酸化CPS2结合物诱导的抗体应答无显著差异。
- 天然CPS2结合疫苗在猪中诱导强IgG应答,并对强毒SS2攻击提供显著保护。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcus suis serotype 2 (SS2) is a major zoonotic pathogen responsible for severe infections in both pigs and humans. Despite its clinical significance, no effective vaccine is currently available, and the influence of capsular polysaccharide (CPS2) structural features on host immunity remains unclear. Here, we identified a fast-growing SS2 strain from a panel of 40 clinical isolates and established a novel, reliable CPS2 purification method. This approach combines polyethylenimine-mediated nucleic acid precipitation with phenol-based protein denaturation, eliminating the need for column chromatography and enabling gram-scale CPS2 recovery per liter of culture while preserving structural integrity. To examine the role of sialic acid, we compared antibody responses induced by native and desialylated CPS2 conjugates in mice, which revealed no significant differences. Based on this finding, a native CPS2 conjugate vaccine was subsequently evaluated in pigs, where it induced robust IgG responses and conferred significant protection against virulent SS2 challenge. The effects of different adjuvants and dosages were also investigated. Collectively, these results establish an efficient CPS2 production platform, clarify the limited impact of sialic acid on conjugate-induced antibody responses, and highlight the potential of CPS2-based conjugates as promising vaccine candidates against SS2 infection.
引用
- Zhong Y, Yang H, Chai W, et al. Development and immunological evaluation of a Streptococcus suis serotype 2 capsular polysaccharide conjugate vaccine. Vaccine. 2025. PMID: 41260175. doi:10.1016/j.vaccine.2025.128004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。